Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men
详细信息 查看全文
- 作者：Frans M.J. Debruyne ; Hermann M. Behre ; Claus G. Roehrborn ; Mario Maggi ; Frederick C.W. Wu ; Fritz H. Schrö ; der ; Thomas Hugh Jones ; Hartmut Porst ; Geoffrey Hackett ; Olivia A. Wheaton ; Antonio Martin-Morales ; Eric Meuleman ; Glenn R. Cunningham ; Hozefa A. Divan ; Raymond C. Rosen and for the RHYME Investigators
- 刊名：BJU International
- 出版年：2017
- 出版时间：February 2017
- 年：2017
- 卷：119
- 期：2
- 页码：216-224
- 全文大小：330K
- ISSN：1464-410X
文摘
To evaluate the effects of testosterone-replacement therapy (TRT) on prostate health indicators in hypogonadal men, including rates of prostate cancer diagnoses, changes in prostate-specific antigen (PSA) levels and lower urinary tract symptoms (LUTS) over time.